These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 18191815)
21. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter. Pifl C; Reither H; Hornykiewicz O Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452 [TBL] [Abstract][Full Text] [Related]
22. Effects of chronic unpredictable stress on monoamine transporter immunoreactivity and methamphetamine-induced dopamine release in the nucleus accumbens shell. Raudensky J; Yamamoto BK Synapse; 2007 May; 61(5):353-5. PubMed ID: 17318887 [No Abstract] [Full Text] [Related]
23. Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. Meyer AC; Neugebauer NM; Zheng G; Crooks PA; Dwoskin LP; Bardo MT J Neurochem; 2013 Oct; 127(2):187-98. PubMed ID: 23875705 [TBL] [Abstract][Full Text] [Related]
24. A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Dwoskin LP; Crooks PA Biochem Pharmacol; 2002 Jan; 63(2):89-98. PubMed ID: 11841781 [TBL] [Abstract][Full Text] [Related]
25. Sex-related differences in striatal dopaminergic system after traumatic brain injury. Xu X; Cao S; Chao H; Liu Y; Ji J Brain Res Bull; 2016 Jun; 124():214-21. PubMed ID: 27210290 [TBL] [Abstract][Full Text] [Related]
26. The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits. Volz TJ; Hanson GR; Fleckenstein AE J Neurochem; 2007 May; 101(4):883-8. PubMed ID: 17250674 [TBL] [Abstract][Full Text] [Related]
27. Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding. Challasivakanaka S; Zhen J; Smith ME; Reith MEA; Foster JD; Vaughan RA J Biol Chem; 2017 Nov; 292(46):19066-19075. PubMed ID: 28939767 [TBL] [Abstract][Full Text] [Related]
29. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046 [TBL] [Abstract][Full Text] [Related]
30. The effects of lobeline and naltrexone on methamphetamine-induced place preference and striatal dopamine and serotonin levels in adolescent rats with a history of maternal separation. Dimatelis JJ; Russell VA; Stein DJ; Daniels WM Metab Brain Dis; 2012 Sep; 27(3):351-61. PubMed ID: 22392627 [TBL] [Abstract][Full Text] [Related]
32. Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters. Zheng G; Horton DB; Deaciuc AG; Dwoskin LP; Crooks PA Bioorg Med Chem Lett; 2006 Oct; 16(19):5018-21. PubMed ID: 16905316 [TBL] [Abstract][Full Text] [Related]
33. Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways. Bourque M; Liu B; Dluzen DE; Di Paolo T Psychoneuroendocrinology; 2011 Aug; 36(7):955-69. PubMed ID: 21236583 [TBL] [Abstract][Full Text] [Related]
34. Hydrogen ion concentration differentiates effects of methamphetamine and dopamine on transporter-mediated efflux. Wilhelm CJ; Johnson RA; Eshleman AJ; Janowsky A J Neurochem; 2006 Feb; 96(4):1149-59. PubMed ID: 16417578 [TBL] [Abstract][Full Text] [Related]